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Haemagglutinin sequences of pandemic influenza 
A(H1N1) viruses circulating in Italy were examined, 
focusing on amino acid changes at position 222 
because of its suggested  pathogenic relevance. 
Among 169 patients, the D222G substitution was 
detected in three of 52 (5.8%) severe cases and in one 
of 117 (0.9%) mild cases, whereas the D222E muta-
tion was more frequent and evenly distributed in mild 
(31.6%) and severe cases (38.4%). A cluster of D222E 
viruses among school children confirms reported 
human-to-human transmission of viruses mutated at 
amino acid position 222.
Introduction 
Influenza viruses are known for their high evolution-
ary rate. Some mutations result in amino acid substi-
tutions at key locations such as antigenic sites or the 
receptor-binding site of the haemagglutinin (HA) pro-
tein, thus potentially altering virus’ antigenicity and/or 
pathogenicity. In most cases, infection with the 2009 
pandemic influenza A(H1N1) virus has caused mild dis-
ease, but there have been sporadic cases with severe 
and fatal outcome. Since the first appearance of this 
virus in April 2009, certain mutations in the HA protein 
have been detected in several countries. In particular 
the substitution of aspartic acid with glycine in posi-
tion 222 (D222G) in the HA1 subunit has been reported, 
initially in Norway, in association with fatal cases [1]. 
The Italian National Influenza Centre (NIC-ISS), in col-
laboration with the regional laboratory network and 
under the supervision of the Ministry of Health, con-
ducted a study with the aim of assessing the distribu-
tion of the genetic changes in HA and their association 
with disease severity, in a convenience sample of 
Italian subjects with confirmed diagnosis of pandemic 
influenza A(H1N1). 
Methods 
We studied respiratory specimens, i.e. throat swabs 
and bronchoalveolar lavages (BAL), collected between 
May 2009 and February 2010 from patients with lab-
oratory-confirmed pandemic influenza. The HA1 gene 
was amplified by RT-PCR using specific primers, as 
previously reported [2], and sequenced with the ABI 
Prism Big Dye Terminator Cycle Ready Reaction kit, ver-
sion 3.1 (Applied Biosystems). The ClustalW algorithm 
included in the BioEdit software version 4.0 (www.
mbio.ncsu.edu/BioEdit/bioedit.html) was used to align 
and analyse the HA1 sequences. Fisher’s exact test 
was used to assess the statistical significance of the 
associations.
Results 
Overall, 169 samples from individuals affected by 
pandemic influenza A(H1N1) were analysed. Of those, 
98 were male and 71 female; the median age was 25 
years (range: 1 to 77 years). In particular, 39% of sam-
ples were from subjects under 18 years of age, 58% 
from people aged 18-64 years and 3% from elderly 
people (over 65 years), as shown in Table 1. Of the 169 
patients, 117 (69%) had mild disease, while 52 (31%) 
were classified as having severe disease according 
to guidance criteria of the World Health Organization 
(WHO) [3]. Among the severe or fatal cases, 58% were 
adults aged 18-64 years, whereas 35% were children 
younger than 18 years (Table 1).
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The area of the HA gene coding for amino acid position 
222 (in the H1 numbering system) was successfully 
amplified and sequenced in all 169 samples included 
in this study.
The overall results are reported in Table 2. Notably, the 
D222G change was detected in four of 169 individu-
als (2.4%). All these four mutant viruses were found 
in patients aged 18-64 years. In particular, this amino 
acid substitution was found in three of 52 severe/fatal 
cases but only in one of 117 mild cases (5.8% versus 
0.9%). Although the odds ratio (OR) tended to be high 
(OR: 7.3; 95% confidence interval (CI): 0.7–72.1), the dif-
ference did not reach statistical significance (Fisher’s 
exact test: p=0.08). It must be highlighted that the one 
mutant pandemic influenza A(H1N1) virus isolated from 
a mild case, a household contact of one of the three 
severe cases carrying the D222G mutation [4], showed 
an additional change in the HA gene (G155E). 
Another amino acid substitution in the same position of 
the HA, D222E, was detected in 57 of the 169 patients 
(33.7%). This common genetic change was similarly 
distributed between mild cases (37 of 117, 31.6%) and 
severe/fatal cases (20 of 52, 38.4%). Interestingly, five 
of the 37 mutant viruses in mild cases were isolated 
from a cluster of seven children with influenza-like 
symptoms, returning to Italy from a school trip to 
England. 
Conclusions
We have previously described the only documented 
transmission event of a D222G mutant pandemic influ-
enza A(H1N1) virus [4]; to the best of our knowledge, 
this mutation appears to be hardly ever transmitted. 
Less is known about the human-to-human transmissi-
bility of D222E virus mutants. In the present study, we 
found that this mutation is much more frequent than 
the 222G mutation and equally distributed between 
severe and mild cases. Particularly we report here on 
a cluster of close contacts carrying the D222E substitu-
tion in a group of high school students with mild dis-
ease returning from England, suggesting inter-human 
transmission of D222E pandemic influenza A(H1N1) 
mutant viruses. However, the clinical significance of 
the D222E substitution remains uncertain [5].
It is of note that the D222G mutation was detected 
more commonly among viruses isolated from severe 
cases, which were about seven times more likely to 
have this genetic change than those isolated from mild 
cases; however, the difference did not reach statisti-
cal significance, probably due to limited study power. 
Further analyses are in progress in order to enlarge our 
data set. 
The D222G variants were detected among adults (18-64 
age group). Whether this was due to the fact that this 
age group had the highest number of cases (includ-
ing severe ones), or to unidentified biological factors, 
remains undefined. In particular, due to the relatively 
limited number of cases with the 222G variant, defini-
tive conclusions about possible age differences cannot 
be drawn.
Studies conducted in other countries, e.g. Norway 
and Scotland, also found D222G to be more common 
among severe than mild cases [1,6]. Although these 
Table 2
Amino acid at position 222 of the HA1 gene of pandemic influenza A(H1N1) viruses, by clinical outcome, Italy, May 2009–
February 2010 (N=169)
Clinical outcomea
Amino acid at HA1 position 222 Mild (n=117)
Severe 
(n=43)
Fatal 
(n=9)
Severe plus fatal 
(n=52)
All cases 
(N=169)
D222 79  (68%)
23 
(53)
6  
(67%)
29 
(56%)
108 
(64%)
E222 37
b
(32%)
18 
(42%)
2  
(22%)
20 
(38%)
57  
(34%)
G222 1
c 
(0.9%)
2c 
(4.7%)
1 
(11%)
3 
(5.8%)
4  
(2.4%)
a Number of cases and the corresponding percentages (in parentheses) are reported within each specific clinical category.
b This group includes a cluster of five high school students, returning from England and likely sharing the source of infection.
c Two cases in these groups are epidemiologically linked: an index case with severe disease and a household contact with mild symptoms [4].
Table 1
Age and sex of pandemic influenza A(H1N1)-positive 
subjects, by clinical outcome, Italy, May 2009–February 
2010 (N=169)
Mild
(n=117)
Severe 
(n=43)
Fatal
(n=9)
All cases
(N=169)
Age group (years)
0-17
18-64
65+
48 (73%)
68 (69%)
1 (20%)
15 (23%)
25 (26%)
3 (60%)
3 (4.6%)
5 (5.1%)
1 (20%)
66
98 
5
Sex
Female
Male
50 (70%)
67 (68%)
16 (23%)
27 (28%)
5 (7.0 %)
4 (4.1%)
71
98
Percentages refer to all cases in each age and sex group.
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results indicate that the 222G variant may be more 
virulent, this association must be interpreted with cau-
tion as the same mutation was detected in mild cases, 
and mixed 222D and 222G virus populations were 
found in original samples and isolates from patients 
with severe disease [7]. Experiments in ferrets do not 
appear to support an association of the 222G substi-
tution with virulence [5]. Moreover, the data could be 
biased by more frequent diagnostic sampling from the 
lower respiratory tract of severe cases. 
In vitro studies show conflicting results. Studies con-
ducted in the United States found the 222G mutation 
only in isolated viruses but not in the original clinical 
samples [5]. On the other hand, preliminary results 
from in vitro studies suggest that D222G substitution 
might enhance binding of HA to alpha2-3 sialic acid 
(avian-like) cell receptors, thus increasing the virus 
ability to infect human lung cells [5,8]. Moreover, stud-
ies from Liu et al. [9] and Chutinimitkul et al. [10] sug-
gest an increased receptor affinity of the 222G variant 
for ciliated bronchial epithelial cells, which may explain 
enhanced disease in humans. Increased binding to 
macrophages and pneumocytes of the respiratory 
tract may indeed have an impact on disease severity 
since those cells are major producers of inflammatory 
cytokines upon viral antigen stimulation [11].
Another amino acid substitution (D222N) has been 
observed in a number of recent studies [1,5,7], how-
ever, no cases with this mutation have been identified 
in the samples analysed here. Finally, our data sug-
gest that the D222G substitution is overall rather infre-
quent, even among severe cases. However, we confirm 
that it occurs with a higher frequency in severe cases. 
Whether this association is indicative of higher viru-
lence or is the consequence of receptor-specific adap-
tive mutation needs to be further investigated.
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